U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 47

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr6:33136731
GRCh38:
Chr6:33168954
COL11A2Autosomal dominant nonsyndromic hearing loss 13Likely pathogenic
(Feb 28, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr6:33133489
GRCh38:
Chr6:33165712
COL11A2not provided, Fibrochondrogenesis 2, Otospondylomegaepiphyseal dysplasia, autosomal recessive,
Autosomal dominant nonsyndromic hearing loss 13, Autosomal recessive nonsyndromic hearing loss 53, Otospondylomegaepiphyseal dysplasia, autosomal dominant
Likely benign
(Nov 2, 2022)
criteria provided, multiple submitters, no conflicts
3.
GRCh37:
Chr6:33140894
GRCh38:
Chr6:33173117
COL11A2not provided, Fibrochondrogenesis 2, Otospondylomegaepiphyseal dysplasia, autosomal recessive,
Autosomal dominant nonsyndromic hearing loss 13, Autosomal recessive nonsyndromic hearing loss 53, Otospondylomegaepiphyseal dysplasia, autosomal dominant
Likely benign
(Jun 27, 2022)
criteria provided, multiple submitters, no conflicts
4.
GRCh37:
Chr6:33146259
GRCh38:
Chr6:33178482
COL11A2T469A, T490A, T576AFibrochondrogenesis 2, Otospondylomegaepiphyseal dysplasia, autosomal recessive, Autosomal dominant nonsyndromic hearing loss 13,
Autosomal recessive nonsyndromic hearing loss 53, Otospondylomegaepiphyseal dysplasia, autosomal dominant, not provided
Conflicting interpretations of pathogenicity
(Aug 10, 2022)
criteria provided, conflicting interpretations
5.
GRCh37:
Chr6:33139581
GRCh38:
Chr6:33171804
COL11A2R913Q, R934Q, R1020Qnot provided, Autosomal dominant nonsyndromic hearing loss 13Conflicting interpretations of pathogenicity
(Sep 20, 2022)
criteria provided, conflicting interpretations
6.
GRCh37:
Chr6:33143428
GRCh38:
Chr6:33175651
COL11A2E681K, E767K, E660Knot provided, Autosomal recessive nonsyndromic hearing loss 53, Fibrochondrogenesis 2,
Otospondylomegaepiphyseal dysplasia, autosomal recessive, Otospondylomegaepiphyseal dysplasia, autosomal dominant, Autosomal dominant nonsyndromic hearing loss 13
Uncertain significance
(Jun 27, 2022)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr6:33156836
GRCh38:
Chr6:33189059
COL11A2R121Hnot provided, Autosomal recessive nonsyndromic hearing loss 53, Fibrochondrogenesis 2,
Otospondylomegaepiphyseal dysplasia, autosomal recessive, Otospondylomegaepiphyseal dysplasia, autosomal dominant, Autosomal dominant nonsyndromic hearing loss 13
Uncertain significance
(Oct 8, 2022)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr6:33139838
GRCh38:
Chr6:33172061
COL11A2P1011T, P925T, P904TAutosomal dominant nonsyndromic hearing loss 13, not providedUncertain significance
(May 22, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr6:33148742
GRCh38:
Chr6:33180965
COL11A2A300V, A321V, A407Vnot provided, Autosomal dominant nonsyndromic hearing loss 13, Otospondylomegaepiphyseal dysplasia, autosomal dominant,
Autosomal recessive nonsyndromic hearing loss 53, Fibrochondrogenesis 2, Otospondylomegaepiphyseal dysplasia, autosomal recessive
Uncertain significance
(Oct 8, 2022)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr6:33156921
GRCh38:
Chr6:33189144
COL11A2R93Cnot provided, Autosomal recessive nonsyndromic hearing loss 53, Fibrochondrogenesis 2,
Autosomal dominant nonsyndromic hearing loss 13, Otospondylomegaepiphyseal dysplasia, autosomal recessive, Otospondylomegaepiphyseal dysplasia, autosomal dominant
Uncertain significance
(Feb 10, 2023)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr6:33137183
GRCh38:
Chr6:33169406
COL11A2D1152N, D1173N, D1259Nnot provided, Autosomal recessive nonsyndromic hearing loss 53, Fibrochondrogenesis 2,
Autosomal dominant nonsyndromic hearing loss 13, Otospondylomegaepiphyseal dysplasia, autosomal recessive, Otospondylomegaepiphyseal dysplasia, autosomal dominant
Uncertain significance
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr6:33147055
GRCh38:
Chr6:33179278
COL11A2P418S, P504S, P397SAutosomal dominant nonsyndromic hearing loss 13Uncertain significance
(Jan 24, 2018)
criteria provided, single submitter
13.
GRCh37:
Chr6:33136530
GRCh38:
Chr6:33168753
COL11A2D1180H, D1201H, D1287Hnot provided, Autosomal dominant nonsyndromic hearing loss 13Uncertain significance
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr6:33137622
GRCh38:
Chr6:33169845
COL11A2E1119K, E1140K, E1226KAutosomal dominant nonsyndromic hearing loss 13, Intellectual disabilityUncertain significance
(Aug 3, 2020)
criteria provided, single submitter
15.
GRCh37:
Chr6:33144251
GRCh38:
Chr6:33176474
COL11A2P603S, P624S, P710SAutosomal dominant nonsyndromic hearing loss 13, Autosomal recessive nonsyndromic hearing loss 53, Hearing impairment
Uncertain significance
(Aug 20, 2019)
criteria provided, single submitter
16.
GRCh37:
Chr6:33152865
GRCh38:
Chr6:33185088
COL11A2Fibrochondrogenesis 2, not provided, Autosomal dominant nonsyndromic hearing loss 13,
Autosomal recessive nonsyndromic hearing loss 53, Otospondylomegaepiphyseal dysplasia, autosomal dominant, Otospondylomegaepiphyseal dysplasia, autosomal recessive
Benign
(Jul 22, 2021)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr6:33134392
GRCh38:
Chr6:33166615
COL11A2Fibrochondrogenesis 2, Autosomal dominant nonsyndromic hearing loss 13, Otospondylomegaepiphyseal dysplasia, autosomal dominant,
not provided, Autosomal recessive nonsyndromic hearing loss 53, Otospondylomegaepiphyseal dysplasia, autosomal recessive
Benign
(Jul 22, 2021)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr6:33136575
GRCh38:
Chr6:33168798
COL11A2not provided, Fibrochondrogenesis 2, Autosomal dominant nonsyndromic hearing loss 13,
Otospondylomegaepiphyseal dysplasia, autosomal dominant, Autosomal recessive nonsyndromic hearing loss 53, Otospondylomegaepiphyseal dysplasia, autosomal recessive
Benign
(Jul 22, 2021)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr6:33157232
GRCh38:
Chr6:33189455
COL11A2D33Nnot provided, Autosomal dominant nonsyndromic hearing loss 13Uncertain significance
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr6:33134834
GRCh38:
Chr6:33167057
COL11A2Autosomal dominant nonsyndromic hearing loss 13, Otospondylomegaepiphyseal dysplasia, autosomal recessive, Fibrochondrogenesis 2,
Autosomal recessive nonsyndromic hearing loss 53, Otospondylomegaepiphyseal dysplasia, autosomal dominant, not provided
Likely benign
(Oct 24, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr6:33154337
GRCh38:
Chr6:33186560
COL11A2P289Snot providedUncertain significance
(Dec 10, 2021)
criteria provided, single submitter
22.
GRCh37:
Chr6:33139582
GRCh38:
Chr6:33171805
COL11A2R1020*, R934*, R913*not provided, Otospondylomegaepiphyseal dysplasia, autosomal recessive, Autosomal recessive nonsyndromic hearing loss 53,
Otospondylomegaepiphyseal dysplasia, autosomal dominant, Autosomal dominant nonsyndromic hearing loss 13, Fibrochondrogenesis 2
Likely pathogenic
(Feb 10, 2022)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr6:33139071
GRCh38:
Chr6:33171294
COL11A2T1097P, T990P, T1011PAutosomal dominant nonsyndromic hearing loss 13, Autosomal recessive nonsyndromic hearing loss 53, Otospondylomegaepiphyseal dysplasia, autosomal recessive,
Otospondylomegaepiphyseal dysplasia, autosomal dominant, Fibrochondrogenesis 2, not provided
Conflicting interpretations of pathogenicity
(Oct 15, 2022)
criteria provided, conflicting interpretations
24.
GRCh37:
Chr6:33136506
GRCh38:
Chr6:33168729
COL11A2E1295K, E1188K, E1209KStickler Syndrome, Dominant, Otospondylomegaepiphyseal dysplasia, autosomal dominant, Fibrochondrogenesis 2,
Otospondylomegaepiphyseal dysplasia, autosomal recessive, Autosomal dominant nonsyndromic hearing loss 13, Autosomal recessive nonsyndromic hearing loss 53,
Otospondylomegaepiphyseal dysplasia, autosomal dominant, not provided, Fibrochondrogenesis 2,
Otospondylomegaepiphyseal dysplasia, autosomal recessive
Conflicting interpretations of pathogenicity
(Jul 6, 2022)
criteria provided, conflicting interpretations
25.
GRCh37:
Chr6:33141253
GRCh38:
Chr6:33173476
COL11A2not provided, Autosomal dominant nonsyndromic hearing loss 13, Otospondylomegaepiphyseal dysplasia, autosomal dominant,
not specified, Fibrochondrogenesis 2, Autosomal recessive nonsyndromic hearing loss 53,
Otospondylomegaepiphyseal dysplasia, autosomal recessive
Benign
(Jul 22, 2021)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr6:33141920
GRCh38:
Chr6:33174143
COL11A2not specified, Autosomal dominant nonsyndromic hearing loss 13, Autosomal recessive nonsyndromic hearing loss 53,
Otospondylomegaepiphyseal dysplasia, autosomal dominant, Otospondylomegaepiphyseal dysplasia, autosomal recessive, Fibrochondrogenesis 2,
not provided
Benign
(Jul 22, 2021)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr6:33138677
GRCh38:
Chr6:33170900
COL11A2Stickler Syndrome, Dominant, not specified, Fibrochondrogenesis 2,
not provided, Autosomal dominant nonsyndromic hearing loss 13, Autosomal recessive nonsyndromic hearing loss 53,
Otospondylomegaepiphyseal dysplasia, autosomal recessive, Otospondylomegaepiphyseal dysplasia, autosomal dominant
Benign
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr6:33154514
GRCh38:
Chr6:33186737
COL11A2G230WStickler Syndrome, Dominant, Autosomal recessive nonsyndromic hearing loss 53, Autosomal dominant nonsyndromic hearing loss 13,
Connective tissue disorder, not provided, Otospondylomegaepiphyseal dysplasia, autosomal dominant,
not specified, Fibrochondrogenesis 2, Otospondylomegaepiphyseal dysplasia, autosomal recessive
Conflicting interpretations of pathogenicity
(Sep 19, 2022)
criteria provided, conflicting interpretations
29.
GRCh37:
Chr6:33152819
GRCh38:
Chr6:33185042
COL11A2G297S, G271SConnective tissue disorder, Fibrochondrogenesis 2, Otospondylomegaepiphyseal dysplasia, autosomal recessive,
Otospondylomegaepiphyseal dysplasia, autosomal dominant, Autosomal recessive nonsyndromic hearing loss 53, Autosomal dominant nonsyndromic hearing loss 13,
not specified, not provided, Autosomal dominant nonsyndromic hearing loss 13,
Otospondylomegaepiphyseal dysplasia, autosomal dominant
Conflicting interpretations of pathogenicity
(Sep 25, 2022)
criteria provided, conflicting interpretations
30.
GRCh37:
Chr6:33140133
GRCh38:
Chr6:33172356
COL11A2A974V, A867V, A888VConnective tissue disorder, not specified, not provided,
Fibrochondrogenesis 2, Otospondylomegaepiphyseal dysplasia, autosomal recessive, Otospondylomegaepiphyseal dysplasia, autosomal dominant
Conflicting interpretations of pathogenicity
(Nov 2, 2022)
criteria provided, conflicting interpretations
31.
GRCh37:
Chr6:33136324
GRCh38:
Chr6:33168547
COL11A2N1311S, N1204S, N1225SStickler Syndrome, Dominant, not specified, not provided,
Fibrochondrogenesis 2, Otospondylomegaepiphyseal dysplasia, autosomal dominant, Otospondylomegaepiphyseal dysplasia, autosomal recessive
Conflicting interpretations of pathogenicity
(Sep 17, 2022)
criteria provided, conflicting interpretations
32.
GRCh37:
Chr6:33132693
GRCh38:
Chr6:33164916
COL11A2R1600Q, R1514Q, R1493QStickler Syndrome, Dominant, Connective tissue disorder, Autosomal recessive nonsyndromic hearing loss 53,
Autosomal dominant nonsyndromic hearing loss 13, Otospondylomegaepiphyseal dysplasia, autosomal dominant, Fibrochondrogenesis 2,
Otospondylomegaepiphyseal dysplasia, autosomal recessive, not specified, not provided,
Fibrochondrogenesis 2, Otospondylomegaepiphyseal dysplasia, autosomal dominantOtospondylomegaepiphyseal dysplasia, autosomal recessive,
...see more
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr6:33144064
GRCh38:
Chr6:33176287
COL11A2R729Q, R622Q, R643QStickler Syndrome, Dominant, not specified, Autosomal recessive nonsyndromic hearing loss 53,
Autosomal dominant nonsyndromic hearing loss 13, Otospondylomegaepiphyseal dysplasia, autosomal dominant, Fibrochondrogenesis 2,
Otospondylomegaepiphyseal dysplasia, autosomal recessive, not provided, Fibrochondrogenesis 2,
Otospondylomegaepiphyseal dysplasia, autosomal recessive, Otospondylomegaepiphyseal dysplasia, autosomal dominant ...see more
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr6:33135285
GRCh38:
Chr6:33167508
COL11A2P1347Q, P1261Q, P1240QAutosomal recessive nonsyndromic hearing loss 53, Autosomal dominant nonsyndromic hearing loss 13, Otospondylomegaepiphyseal dysplasia, autosomal recessive,
Otospondylomegaepiphyseal dysplasia, autosomal dominant, Fibrochondrogenesis 2, not provided,
not specified
Conflicting interpretations of pathogenicity
(Oct 17, 2022)
criteria provided, conflicting interpretations
35.
GRCh37:
Chr6:33152835
GRCh38:
Chr6:33185058
COL11A2Stickler Syndrome, Dominant, Connective tissue disorder, not specified,
not provided, Fibrochondrogenesis 2, Autosomal dominant nonsyndromic hearing loss 13,
Autosomal recessive nonsyndromic hearing loss 53, Otospondylomegaepiphyseal dysplasia, autosomal dominant, Otospondylomegaepiphyseal dysplasia, autosomal recessive
Benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr6:33153528
GRCh38:
Chr6:33185751
COL11A2E276KStickler Syndrome, Dominant, not specified, not provided,
Fibrochondrogenesis 2, Autosomal dominant nonsyndromic hearing loss 13, Otospondylomegaepiphyseal dysplasia, autosomal recessive,
Autosomal recessive nonsyndromic hearing loss 53, Otospondylomegaepiphyseal dysplasia, autosomal dominant
Benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr6:33138955
GRCh38:
Chr6:33171178
COL11A2Stickler Syndrome, Dominant, not specified, not provided,
Fibrochondrogenesis 2, Autosomal recessive nonsyndromic hearing loss 53, Autosomal dominant nonsyndromic hearing loss 13,
Otospondylomegaepiphyseal dysplasia, autosomal recessive, Otospondylomegaepiphyseal dysplasia, autosomal dominant
Benign
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr6:33139328
GRCh38:
Chr6:33171551
COL11A2not specified, Stickler Syndrome, Dominant, not provided,
Fibrochondrogenesis 2, Autosomal dominant nonsyndromic hearing loss 13, Otospondylomegaepiphyseal dysplasia, autosomal recessive,
Autosomal recessive nonsyndromic hearing loss 53, Otospondylomegaepiphyseal dysplasia, autosomal dominant
Benign
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr6:33139475
GRCh38:
Chr6:33171698
COL11A2Stickler Syndrome, Dominant, not specified, not provided,
Fibrochondrogenesis 2, Autosomal dominant nonsyndromic hearing loss 13, Otospondylomegaepiphyseal dysplasia, autosomal recessive,
Autosomal recessive nonsyndromic hearing loss 53, Otospondylomegaepiphyseal dysplasia, autosomal dominant
Benign
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr6:33141161
GRCh38:
Chr6:33173384
COL11A2not specified, Stickler Syndrome, Dominant, not provided,
Fibrochondrogenesis 2, Autosomal dominant nonsyndromic hearing loss 13, Otospondylomegaepiphyseal dysplasia, autosomal recessive,
Autosomal recessive nonsyndromic hearing loss 53, Otospondylomegaepiphyseal dysplasia, autosomal dominant
Benign
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr6:33141475
GRCh38:
Chr6:33173698
COL11A2not specified, Stickler Syndrome, Dominant, not provided,
Fibrochondrogenesis 2, Otospondylomegaepiphyseal dysplasia, autosomal recessive, Autosomal recessive nonsyndromic hearing loss 53,
Autosomal dominant nonsyndromic hearing loss 13, Otospondylomegaepiphyseal dysplasia, autosomal dominant
Benign
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr6:33144243
GRCh38:
Chr6:33176466
COL11A2Stickler Syndrome, Dominant, not provided, not specified,
Fibrochondrogenesis 2, Autosomal dominant nonsyndromic hearing loss 13, Otospondylomegaepiphyseal dysplasia, autosomal recessive,
Otospondylomegaepiphyseal dysplasia, autosomal dominant, Autosomal recessive nonsyndromic hearing loss 53
Benign
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr6:33147589
GRCh38:
Chr6:33179812
COL11A2Stickler Syndrome, Dominant, not specified, not provided,
Fibrochondrogenesis 2, Autosomal dominant nonsyndromic hearing loss 13, Otospondylomegaepiphyseal dysplasia, autosomal recessive,
Autosomal recessive nonsyndromic hearing loss 53, Otospondylomegaepiphyseal dysplasia, autosomal dominant
Benign
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr6:33135599
GRCh38:
Chr6:33167822
COL11A2R1224*, R1245*, R1331*Autosomal recessive nonsyndromic hearing loss 53, Otospondylomegaepiphyseal dysplasia, autosomal dominant, Autosomal dominant nonsyndromic hearing loss 13,
Otospondylomegaepiphyseal dysplasia, autosomal recessive, Fibrochondrogenesis 2, not provided
Pathogenic
(Jul 28, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr6:33135082
GRCh38:
Chr6:33167305
COL11A2R1272*, R1293*, R1379*Autosomal dominant nonsyndromic hearing loss 13, Otospondylomegaepiphyseal dysplasia, autosomal dominant, not provided
Pathogenic/Likely pathogenic
(Sep 30, 2022)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr6:33142311
GRCh38:
Chr6:33174534
COL11A2G701E, G722E, G808EAutosomal dominant nonsyndromic hearing loss 13Pathogenic
(Dec 1, 1999)
no assertion criteria provided
47.
GRCh37:
Chr6:33139540
GRCh38:
Chr6:33171763
COL11A2R1034C, R927C, R948CRare genetic deafness, not providedPathogenic/Likely pathogenic
(Oct 31, 2022)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination